2022 - Research.com Microbiology in Sweden Leader Award
Joakim Dillner mainly focuses on Cervical cancer, Gynecology, Immunology, Internal medicine and Cervical intraepithelial neoplasia. The various areas that Joakim Dillner examines in his Cervical cancer study include Meta-analysis and Vaccination. Joakim Dillner has researched Gynecology in several fields, including Colposcopy, Cervical screening, Mass screening, Cytology and Obstetrics.
Joakim Dillner combines subjects such as Papillomavirus Vaccines and Virology with his study of Immunology. His research on Internal medicine frequently connects to adjacent areas such as Oncology. His Cervical intraepithelial neoplasia study combines topics from a wide range of disciplines, such as Cervarix, Incidence and Confidence interval.
Cervical cancer, Internal medicine, Virology, Immunology and Gynecology are his primary areas of study. The Cervical cancer study combines topics in areas such as Vaccination and Obstetrics. He regularly ties together related areas like Oncology in his Internal medicine studies.
His study looks at the relationship between Virology and topics such as Antibody, which overlap with Molecular biology. His Immunology research is multidisciplinary, incorporating elements of Epidemiology and HPV infection. His research investigates the connection with Gynecology and areas like Cohort study which intersect with concerns in Cohort.
Joakim Dillner spends much of his time researching Human papillomavirus, Internal medicine, Cervical cancer, Cervical screening and Vaccination. His Human papillomavirus research incorporates elements of Cancer, Incidence, Herd immunity, Hpv types and Vaccine efficacy. The concepts of his Internal medicine study are interwoven with issues in Sick leave and Oncology.
His Cervical cancer research incorporates themes from Randomized controlled trial and Deep sequencing. His study focuses on the intersection of Cervical screening and fields such as Obstetrics with connections in the field of Colposcopy, Cytology, Cervical cancer incidence and Cancer screening. His Vaccination study also includes
His primary areas of study are Cervical screening, Internal medicine, Obstetrics, Cervical cancer and Vaccination. Joakim Dillner has included themes like Odds ratio, Lower risk and Clear cell carcinoma in his Cervical screening study. His Internal medicine study integrates concerns from other disciplines, such as Viral load and Oncology.
His research related to Colposcopy and Cervical intraepithelial neoplasia might be considered part of Cervical cancer. His work deals with themes such as Hpv vaccination, Pediatrics, Confidence interval and Human papillomavirus, which intersect with Vaccination. Joakim Dillner combines subjects such as Cancer, Herd immunity, Young adult, Hpv types and Vaccine efficacy with his study of Human papillomavirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen.
The New England Journal of Medicine (2007)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco;Joakim Dillner;K Miriam Elfström;Sara Tunesi.
The Lancet (2014)
Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck
Mork J;Lie Ak;Glattre E;Hallmans G.
The New England Journal of Medicine (2001)
Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
Pontus Naucler;Walter Ryd;Sven Törnberg;Anders Strand.
The New England Journal of Medicine (2007)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick;Marc Arbyn;Rengaswamy Sankaranarayanan;Vivien Tsu.
Vaccine (2008)
Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine
Clayton D. Harro;Yuk Ying Susana Pang;Richard B.S. Roden;Allan Hildesheim.
Journal of the National Cancer Institute (2001)
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses
Marc Arbyn;Peter Sasieni;Chris J.L.M. Meijer;Christine Clavel.
Vaccine (2006)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joakim Dillner;Matejka Rebolj;Philippe Birembaut;Karl Ulrich Petry.
BMJ (2008)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J.L.M. Meijer;Johannes Berkhof;Philip E. Castle;Albertus T. Hesselink.
International Journal of Cancer (2009)
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Keng-Ling Wallin;Fredrik Wiklund;Tord Ångström;Frank Bergman.
The New England Journal of Medicine (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Karolinska Institute
University of Helsinki
Karolinska Institute
Umeå University
Ghent University
National Institutes of Health
University of Copenhagen
Umeå University
Karolinska Institute
Centro di Riferimento Oncologico
Amazon (United States)
Institut de Ciència de Materials de Barcelona
University of Chicago
University of Sydney
Zhejiang University
University of Bonn
Spanish National Research Council
University of Miami
Baylor College of Medicine
University of Las Palmas de Gran Canaria
Academia Sinica
University of Sydney
Hokkaido University
University of Oxford
University of Maryland, College Park
National Institute for Astrophysics